Tara Bancroft
Stock Analyst at TD Cowen
(2.79)
# 1,864
Out of 4,947 analysts
8
Total ratings
66.67%
Success rate
20.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Initiates: Buy | $50 | $27.77 | +80.05% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $55.03 | +18.13% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $12.65 | -13.04% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.45 | +589.66% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $66.94 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $7.38 | - | 1 | Aug 31, 2022 |
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $27.77
Upside: +80.05%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $55.03
Upside: +18.13%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $12.65
Upside: -13.04%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.45
Upside: +589.66%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $66.94
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $7.38
Upside: -